Advertisement

Magnetic Resonance in Experimental and Clinical Oncology

Proceedings of the 21st Annual Detroit Cancer Symposium Detroit, Michigan, USA — April 13 and 14, 1989

  • Jeffrey L. Evelhoch
  • William Negendank
  • Frederick A. Valeriote
  • Laurence H. Baker

Part of the Developments in Oncology book series (DION, volume 61)

Table of contents

  1. Front Matter
    Pages i-xv
  2. John C. Chatham, Jerry D. Glickson
    Pages 1-22
  3. Jeffrey L. Evelhoch, Nicholas E. Simpson, Frederick A. Valeriote, Thomas H. Corbett
    Pages 121-147
  4. Laurel O. Sillerud, Karen R. Halliday, James P. Freyer, Richard H. Griffey, Cecilia Fenoglio-Preiser
    Pages 149-179
  5. John K. Saunders, Ian C. P. Smith
    Pages 181-198
  6. T. R. Brown, S. J. Nelson, J. S. Taylor, D. B. Vigneron, J. Murphy-Boesch
    Pages 199-207
  7. J. A. Koutcher, D. Ballon, M. C. Graham, J. Healey, R. Heelan, L. Gerweck
    Pages 209-230
  8. Thian C. Ng, S. Vijayakumar, A. Majors, Melvin Tefft
    Pages 231-253
  9. Michael A. Shinkwin, Robert E. Lenkinski, Michael B. Zlatkin, Herbert Y. Kressel, John M. Daly
    Pages 255-269
  10. G. S. Karczmar, D. J. Meyerhoff, B. Hubesch, M. D. Boska, F. Valone, D. B. Twieg et al.
    Pages 271-291
  11. W. G. Negendank, M. G. Crowley, J. R. Ryan, N. A. Keller, J. L. Evelhoch
    Pages 293-307
  12. L. L. Sensenbrenner, C. Karanes, L. Tranchida, V. Ratanatharathorn, A. M. Al-Katib, M. R. Smith et al.
    Pages 353-369
  13. John K. Gohagan, Alice E. Tome, William A. Murphy, Edward L. Spitznagel, William G. Negendank, Nancy O. Whitley
    Pages 370-382
  14. Back Matter
    Pages 383-391

About this book

Introduction

Over the past decade, techniques have been developed and implemented to observe metabolism noninvasively in localized regions of intact, living experimental animals and humans through the use of magnetic resonance spectroscopy (MRS). At the same time, magnetic resonance imaging (MRI) techniques developed in the 1970s and refined in this decade have been increasingly applied as a powerful clinical tool to probe human anatomy. Because of the unusual metabolic and physiologic characteristics of malignant tissues, oncology has been one of the primary focuses of the application of both MRS and MRI. Although considerable progress has been made in oncologic applications of magnetic resonance (MR), further research is needed to realize the full potential of MR in this area. Consequently, the 21st Annual Detroit Cancer Symposium entitled "Magnetic Resonance in Experimental and Clin­ ical Oncology" was organized to provide a forum for researchers in the field to report the state of the art of MRS and MRI in oncol­ ogy, to discuss future goals for MRS and MRI in oncology, and to define the research needed to meet those goals. The major emphasis of the symposium was on MRS due to both the recent widespread availability of clinical MRS instrumentation and the extensive amount of animal MRS research performed over the past half decade.

Keywords

Tumor carcinoma diagnosis imaging magnetic resonance imaging (MRI) magnetic resonance spectroscopy

Editors and affiliations

  • Jeffrey L. Evelhoch
    • 1
  • William Negendank
    • 1
  • Frederick A. Valeriote
    • 1
  • Laurence H. Baker
    • 1
  1. 1.Wayne State University School of MedicineDetroitUSA

Bibliographic information